- EUR/USD gives away initial gains on IFO.
- Markets’ focus remains on the Wuhan virus.
- German IFO missed expectations in January.
After moving to daily highs in the 1.1040 region, EUR/USD is now losing the grip and drops to fresh yearly lows in the 1.1020/15 band.
EUR/USD offered on poor IFO
The pair is now accelerating the downside, losing ground for the third session in a row and printing new 2020 lows around 1.1015 after the German IFO survey came in below expectations in all of its components for the current month.
Indeed, the key Business Climate component dropped to 95.9 from 96.3 (vs. 97.0 exp.), Current Assessment ticked higher to 99.1 (99.2 exp.) and Business Expectations inched lower to 92.9 from 93.9.
In the meantime, the pair continues to follow the developments from the coronavirus in China, where it continues to spread and cloud the global growth prospects.
There are no more publications in Euroland on Monday, whereas December’s New Home Sales will be the only release of note across the pond.
What to look for around EUR
The pair stays well on the defensive and trading in levels last seen in December 2019 around 1.1020/15. Dynamics around the buck are expected to remain the exclusive driver of the pair’s price action for the time being along with alternating risk appetite trends in response to developments from the US-China trade front. In the shorter term, investors will also assess news of the Wuhan virus vs. prospects of global growth. On another scenario, the ECB is expected to finish its strategic review (announced last Thursday) by year-end, leaving speculations of any change of the monetary policy before that time pretty flat. Further out, some better-than-expected results in the euro region as of late seem to have lent support to the idea that the bloc could have left the worst behind, although that view looks premature, to say the least.
EUR/USD levels to watch
At the moment, the pair is retreating 0.04% at 1.1019 and a breakdown of 1.1017 (weekly/2020 low Jan.27) would target 1.1000 (psychological level) en route to 1.0981 (monthly low Nov.29 2019). On the flip side, the next hurdle aligns at 1.1068 (100-day SMA) seconded by 1.1089 (55-day SMA) and finally 1.1130 (200-day SMA).
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.